- Investing Ideas
- /
- Global Top Stock Picks from Analysts
Global Top Stock Picks from Analysts
Results
3829
Companies which are more than 50% undervalued based on analyst price target.
3,829 companies
Rapid Nutrition
Market Cap: €826.0k
A natural healthcare company, develops and distributes science-based health and wellness products worldwide.
ALRPD
€0.0057
7D
9.6%
1Y
-91.9%
Leafly Holdings
Market Cap: US$914.2k
Operates as an online cannabis discovery marketplace and resource in the United States and internationally.
LFLY
US$0.29
7D
14.6%
1Y
-84.0%
Pineapple Financial
Market Cap: US$828.7k
Provides mortgage brokerage services and technology solutions to mortgage agents, brokers, sub-brokers, and brokerages and consumers in Canada.
PAPL
US$0.086
7D
-23.0%
1Y
-93.4%
GRI Bio
Market Cap: US$814.3k
A clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States.
GRI
US$1.49
7D
-22.0%
1Y
-98.3%
LogicMark
Market Cap: US$805.8k
Provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States.
LGMK
US$0.014
7D
-12.3%
1Y
-99.9%
cbdMD
Market Cap: US$743.7k
Produces and distributes various cannabidiol (CBD) products in the United States.
YCBD
US$1.01
7D
-1.4%
1Y
-82.2%
OMNIQ
Market Cap: US$699.2k
Provides artificial intelligence-based solutions in the United States.
OMQS
US$0.05
7D
-16.5%
1Y
-83.3%
Nature's Miracle Holding
Market Cap: US$576.3k
An agriculture technology company, provides lighting and grow media products to growers in the controlled environment agriculture industry in the United States and Canada.
NMHI
US$0.084
7D
-34.7%
1Y
-99.7%
Scandion Oncology
Market Cap: SEK 4.6m
A clinical-stage biotechnology company, develops medicines for the treatment of cancer.
SCOL
SEK 0.019
7D
15.5%
1Y
-98.6%
Altamira Therapeutics
Market Cap: US$405.8k
Operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe.
CYTO.F
US$0.071
7D
-28.9%
1Y
-95.1%
Spineway
Market Cap: €101.6k
Engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column.
ALSPW
€0.12
7D
-3.2%
1Y
-76.2%
Ngenic
Market Cap: SEK 614.3k
Provides digitalized energy services for consumers, property owners, and energy companies in Sweden.
NGENIC
SEK 0.09
7D
-11.1%
1Y
-98.3%
Formation Minerals
Market Cap: US$20.0k
Acquires and manages oil and gas minerals and royalties in the United States.
FOMI
US$0.0002
7D
0%
1Y
-99.4%